COMMUNIQUÉS West-GlobeNewswire

48North Joins Forces with Mother & Clone to License Sublingual Nanospray in Canada -- CFN Media

01/10/2018 - 14:30

SEATTLE, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Aurora Orders Big; Larger-Size Orders Surge

01/10/2018 - 14:30

CORONA, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- MedTainer Inc. (ACOL-OTC) announced today that Aurora Cannabis (OTCMARKETS:ACBFF,TSE:ACB) has placed its’ 7th order for thousands of MedTainers in anticipation of the [...]

Novo Nordisk A/S - Share repurchase programme

01/10/2018 - 14:26

Bagsværd, Denmark, 1 October 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]

Melinta Therapeutics and Menarini Group Enter Commercial Agreement for Vabomere™ (meropenem and vaborbactam), Orbactiv® (oritavancin) and Minocin® (minocycline) for Injection in 68 Countries

01/10/2018 - 14:15

- Total consideration of up to $265 million (including potential royalties) - - Expands on existing commercial and co-development agreement for Baxdela ® (delafloxacin) - NEW HAVEN, Conn. and FLORENCE, Italy, Oct. 01, [...]

BeiGene Presents Results on Anti-PD-1 Antibody Tislelizumab in Chinese Patients with Lung Cancers at the Annual Meeting of the Chinese Society of Clinical Oncology

21/09/2018 - 05:38

BEIJING, China, and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Molecular Templates, Inc. Announces Pricing of Public Offering of Common Stock

21/09/2018 - 02:41

AUSTIN, Texas, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of proprietary engineered toxin bodies [...]

CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares

21/09/2018 - 02:33

ZUG, Switzerland and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]

Medtronic to Acquire Mazor Robotics

21/09/2018 - 00:58

Acquisition to Accelerate Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Fully-Integrated Surgical Solutions DUBLIN and CAESAREA, Israel - September 20, 2018 - Medtronic plc (NYSE:MDT [...]

Karmanos Cancer Institute’s 25th Annual Partners Night Friday, Sept. 21, at historic Michigan Building Theatre

20/09/2018 - 23:40

Honoring Jack D. Sobel, M.D. Dean, Wayne State University School of Medicine; Proceeds benefit pancreatic cancer research DETROIT, Sept. 20, 2018 (GLOBE NEWSWIRE) -- On Friday, Sept. 21, the Barbara Ann Karmanos Cancer [...]

Supernus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference

20/09/2018 - 23:28

ROCKVILLE, Md., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]

New Intermountain Transformation Center to Lead Healthcare Delivery Advancement

20/09/2018 - 23:02

New Kem C. Gardner Intermountain Transformation Center is home to institutes and programs that are transforming the way medical care is provided. Salt Lake City, UTAH, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Intermountain [...]

ContraFect to Present at Two Upcoming Investor Conferences

20/09/2018 - 23:00

YONKERS, N.Y., Sept. 20, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]

aTyr Pharma to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference

20/09/2018 - 22:38

SAN DIEGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

Project HOPE Team Responds to Urgent Health Needs as Venezuelans Flee

20/09/2018 - 22:34

Millwood, VA, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Project HOPE announced today that it is deploying an emergency response team to address an exodus of people fleeing political turmoil and an economic collapse in [...]

Thrive Health and Wellness Festival Canmore

20/09/2018 - 22:07

Ticket sales begin for the inaugural Bow Valley festival CANMORE, Alberta, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Today, Thrive, the first Health and Wellness festival in the Bow Valley, announced that they have released [...]

Rubius Therapeutics to Participate in the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology

20/09/2018 - 22:05

CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, announced today that [...]

Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

20/09/2018 - 22:05

RADNOR, Pa., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]

Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003, Nasal Nalmefene, for Treatment of Opioid Overdose

20/09/2018 - 22:05

SANTA MONICA, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, today [...]

XBiotech annonce l’arrivée du Dr Alice Gottlieb au sein de son équipe, une dermatologue et chercheuse de renom

20/09/2018 - 22:04

AUSTIN, Texas, 20 sept. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ : XBIT) annonce aujourd’hui l’arrivée du Dr Alice Gottlieb (M.D., Ph.D.) au sein de son comité scientifique consultatif (Scientific Advisory Board, [...]